Comparison of Conventional Nasal Douching with Corticosteroid Nasal Douching in Chronic Rhinosinusitis Patients Post Surgery

ObjectivesChronic rhinosinusitis has a preponderance for recurrence even after functional endoscopic sinus surgery. Nasal Douching with saline has been used for decades as a treatment and as an adjunct following surgery. Steroid nasal wash has been introduced recently for the postoperative management of patients with chronic rhinosinusitis. The objective of this study was to evaluate the efficacy of postoperative steroid irrigation in patients with chronic rhinosinusitis with and without polyps.MethodsThis prospective study was done over a period of 2 years involving 70 chronic rhinosinusitis patients with and without nasal polyps who underwent functional endoscopic sinus surgery. The patients were divided into two groups, in group A, patients were given saline nasal douching and in group B, the budesonide nasal douching. The 22-item Sinonasal Outcomes Test (SNOT-22) and Lund-Kennedy endoscopy scores were checked before and 1, 2, 4, and 6 months after the nasal irrigation.ResultsIn group A, the mean SNOT-22 score improved from 52.5 +/- 9.1 before irrigation to 22.1 +/- 11.3 after 6 months of irrigation. The LK endoscopy score also improved from 7.2 +/- 2.1 before irrigation to 2.1 +/- 1.2 after 6 months. In group B, the mean SNOT-22 score improved from 48.9 +/- 10.6 before irrigation to 19.8 +/- 11.7 after 6 months of irrigation. The endoscopy score also improved from 6.9 +/- 2.3 before irrigation to 1.5 +/- 1.1 after 6 months. The mean SNOT-22 and Lund-Kennedy scores improved in both groups. Group B with budesonide irrigation was found to have improved significantly than the saline nasal irrigation group, however, the difference between the 2 groups was not significant.ConclusionNasal douching with budesonide is an effective postoperative treatment for chronic rhinosinusitis with polyps. The addition of budesonide in douching improves the quality of life and reduces the chance of recurrence.